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Bovine viral diarrhea virus (BVDV) infects members of the order
Artiodactyla (Wengler, 1991) and is an important bovine pathogen
having negative impacts on beef and dairy production (Booker et al.,
2008; Fourichon et al., 2005; Houe, 2003). BVDV causes gastroenter-
itis, immunosuppression and abortion in infected cattle (Galav et al.,
2007; Janzen and Clark, 1995; Kelling et al., 1990). The most insidious
effect of BVDV infection is the causation of persistently-infected (PI)
calves and crias, due to in utero infection and immunotolerance of the
fetus to the infecting BVDV strain. PI animals shed virus throughout
their lifetime and provide a reservoir of BVDV infection in herds
(McClurkin et al., 1985; Topliff et al., 2009).
BVDV is an enveloped Pestivirus with a positive-sense, single-
stranded RNA genome approximately 12.3 kb in length, encoding
eleven or twelve proteins in one long open reading frame (Wengler,
1991). Based on comparison of genetic sequences, BVDV isolates can
be grouped into BVDV1 and BVDV2 (Ridpath et al., 1994; Thiel et al.,
2005) with isolates varying in virulence (Kelling et al., 2002; Topliff
and Kelling, 1998).After infection with BVDV, the ﬁrst line of cellular defense is
interferon (IFN) synthesis. Interferons are inducible cytokines which
defend the host against infection by activating cellular factors to shut
down viral mRNA synthesis and degrade viral RNA (Castelli et al.,
1997) and to promote the activity of natural killer cells (Sato et al.,
2001), B cells (Jego et al., 2003; Litniskiy et al., 2002) and T cells
(Foster et al., 2004; Le Bon et al., 2003; Rogge et al., 1998) for systemic
protection. Evasion of this host immune response is crucial for both
acute and persistent infections with BVDV. BVDV has been shown to
inhibit the synthesis of IFN (Schweizer et al., 2006) and can also
inhibit production of molecules stimulated by IFN synthesis such as
Mx protein (Schweizer and Peterhans, 2001).
While BVDV is well-recognized as a cause of both acute and
persistent infections in cattle, it was previously thought that New
World camelids, such as alpacas, were resistant to infection with
BVDV (Wentz et al., 2003). However, occurrences of PI alpacas have
recently been reported (Carman et al., 2005; Foster et al., 2007; Goyal
et al., 2002; Mattson et al., 2006; Topliff et al., 2009). Previous work
indicates that clinical effects of post-natal BVDV infections of New
World camelids are diminished in comparison to infections of cattle
(Wentz et al., 2003).
Reports of BVDV prevalence (Topliff et al., 2009) and infection in
alpacas have prompted investigations into mechanisms of BVDV
infection of non-bovine host species. In this study, we characterized
the differences in permissivity and IFN response of alpaca and bovine
cells to BVDV infection to elucidate mechanisms underlying the
differences in clinical disease signs and infections between cattle and
alpacas. Results showed that alpaca cells have limited permissiveness
to BVDV infection with corresponding elevated levels of IFN synthesis
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BVDV infection of alpacas and cattle.Results
Viral replication in ruminant cells
Viral replication was characterized for each BVDV isolate in alpaca
testicular (AT) and bovine turbinate (BT) cells. BVDV-speciﬁc
cytoplasmic antigen in alpaca cells stained less intensely and less
frequently compared to bovine cells (Figs. 1 and 2). AT cells infected
with the BVDV1 alpaca origin isolate CO-06 had a greater frequency of
viral antigen staining, with the majority of cells stained, as opposed to
isolated clusters of stained cells seen in AT cells infected with the
other BVDV isolates, NY-1, 890 and 7937. The reduction in
cytoplasmic viral antigen staining was most apparent in AT cells
infected with the BVDV2 isolates, 890 and 7937 wherein speciﬁc
cytoplasmic staining of viral antigen occurred in isolated clusters of
cells with less intense staining than observed in infected BT cells
(Fig. 2). The greater frequency and intensity of BVDV1 CO-06 viral
antigen staining in AT cells when compared to BVDV2 isolates
correlates with calculated titer means (Figs. 3 and 4). BVDV1, CO-06,
replicated 1 log TCID50 greater than BVDV2, 890 or 7937 in AT cells.Fig. 1. Enzyme-linked immunoassay of alpaca testicular (AT) and bovine turbinate (BT) cells
infected AT cells; (B) Mock-infected BT cells; (C) BVDV CO-06-infected AT cells; (D) BVDV COThe BVDV1, NY-1, titer mean was similar to the BVDV2 isolates in AT
cells.
Differences in the rate of viral replication in AT and BT cells were
observed (Figs. 3 and 4), 12 hour post-infection for three of the four
viral isolates. BVDV1, NY-1, had a 2.2 log TCID50 greater titer in BT
than AT cells (Fig. 3), as did BVDV2, 7937 and 890 (Fig. 4), with titers
1.24 and 2.87 log TCID50 greater in BT than AT cells, respectively. At
24 hour post-infection, mean titers in AT cells infected with BVDV NY-
1 or CO-06 were statistically (p=0.0372) lower than infected BT cells
(Fig. 3). Mean titers of BVDV 7937 infected BT cells were signiﬁcantly
(p=0.0209) greater than AT cells beginning 48 hour post-infection.
At 72 hour post-infection, titers in BT cells were 3 to 5 log TCID50
greater than AT cells.
BVDV total mean viral titer, the mean titer of the time points for
each BVDV strain in each cell type was determined. Signiﬁcant
differences were found between the total mean viral titers in alpaca
and bovine cells infected with the BVDV1 viruses, CO-06 and NY-1,
with signiﬁcantly higher mean titers observed in BT cells compared to
AT cells, p=0.0011 and p=b 0.001, respectively. Similarly, signiﬁcant
differences were also found between alpaca and bovine cells infected
with the BVDV2 viruses, 890 (p=b0.001) and 7937 (p=0.001), with
a signiﬁcantly greater mean titer in BT cells compared to AT cells. At
72 hour post-infection, the end titer of BVDV1 viruses in AT cells was
signiﬁcantly (p=0.0238) greater than the end titers of BVDV2 virusesinfected with BVDV1 viruses NY-1 (bovine origin) and CO-06 (alpaca origin). (A) Mock-
-06-infected BT cells; (E) BVDV NY-1-infected AT cells; (F) BVDV NY-1-infected BT cells.
Fig. 2. Enzyme-linked immunoassay of alpaca testicular (AT) and bovine turbinate (BT) cells infected with BVDV2 viruses 890 (high virulence) and 7937 (low virulence). (A) Mock-
infected AT cells; (B) Mock-infected BT cells; (C) BVDV 890-infected AT cells; (D) BVDV 890-infected BT cells; (E) BVDV 7937-infected AT cells; (F) BVDV 7937-infected BT cells.
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cells was signiﬁcantly (p=0.0307) greater than that of the bovine
origin BVDV NY-1, as well as the BVDV2 isolates BVDV 890 and 7937
(p=0.0344) in AT cells. This difference between ﬁnal titers of BVDV1Fig. 3. Viral replication of BVDV1 isolates NY-1 and CO-06 in alpaca testicular (AT) and
bovine turbinate (BT) cells. Cell lysates were harvested at 0, 1.5, 3, 6, 9, 12, 18, 24, 48,
and 72 hour post-infection and assayed for viral infectivity. *Statistically signiﬁcant
between cell types at p≤0.05.and BVDV2 viruses was not signiﬁcant (p=0.1340) in BT cells,
although BVDV CO-06 replicated to a signiﬁcantly higher (p=0.0140)
end titer than the low virulence BVDV2 isolate 7937 but not the high
virulence isolate BVDV 890 (p=0.4226). There was no signiﬁcant
difference in viral replication between the alpaca origin isolate CO-06Fig. 4. Viral replication of BVDV2 isolates 890 (high virulence) and 7937 (low virulence)
in alpaca testicular (AT) and bovine turbinate (BT) cells. Cell lysates were harvested at
0, 1.5, 3, 6, 9, 12, 18, 24, 48, and 72 hour post-infection and assayed for viral infectivity.
*Statistically signiﬁcant between cell types at p≤0.05.
Fig. 5. Type I interferon (IFN) responses of alpaca testicular (AT) and bovine turbinate
(BT) cells infected with BVDV CO-06 or NY-1 at an m.o.i. of 10. Cell lysates were
harvested 24 hour post-infection, clariﬁed by centrifugation and virus inactivated. Test
samples were added to NCL1-Luc-ISRE-Hygro cells, incubated for 8 hours and cell
lysates analyzed for luciferase activity. *Differences from other groups are statistically
signiﬁcant at p≤0.05.
114 H.C. Samson et al. / Virology 413 (2011) 111–117and the bovine origin isolate NY-1 (p=0.4480). At 72 hour post-
infection, signiﬁcant differences were not observed between BVDV
890 and 7937 in AT cells (p=0.5044). However, the titer of BVDV 890
was signiﬁcantly higher (p=0.0006) than BVDV 7937 in BT cells.
IFN response of ruminant cells to BVDV infection
IFN responses in AT and BT cells were measured following BVDV
infection (Fig. 5). BVDV NY-1 and CO-06 were poor inducers of IFN
responses in AT and BT cells. Following stimulation with poly I:C., AT
cells had a signiﬁcantly greater IFN response, synthesizing up to 5
times more IFN, than that of BT cells (p=0.0006) (Fig. 5). AT and BT
cells infectedwith BVDVNY-1 or CO-06 and then stimulatedwith poly
I:C 48 hour post-infection (Fig. 6) showed signiﬁcant differences in
the inhibition of IFN activity. AT cells infected with either BVDV NY-1
or CO-06, then stimulated with poly I:C synthesized signiﬁcantly
greater IFN than AT cells following infection alone (p=b0.0001 and
p=0.0002, respectively). Similarly, BT cells infected with BVDV CO-Fig. 6. Inhibition of IFN synthesis by BVDV infection of alpaca testicular (AT) and bovine
turbinate (BT) cells. Subconﬂuent AT or BT cells were infected with BVDV1 NY-1 or CO-
06 at an m.o.i. of 1, incubated for 48 hours, then treated with growth media without
(−) or with poly I:C (+) at a concentration of 50 μg/ml. Following incubation for
20 hours, cell lysates were harvested and virus inactivated. Test samples were added to
NCL1-Luc-ISRE-Hygro cells, incubated for 8 hours, cells lysed and luciferase activity
measured. *Differences from other groups are statistically signiﬁcant at p≤0.05.06 synthesized signiﬁcantly (p=0.0339) greater IFN following poly I:
C stimulation than BT cells following infection alone. BT cells infected
with NY-1 had no signiﬁcant (p=0.5899) increase in IFN production
following poly I:C stimulation compared to non-stimulated, NY-1
infected BT cells.
Therewere signiﬁcant differences in IFN inhibition between the AT
and BT cells. AT cells infected with BVDV CO-06 or NY-1 synthesized
signiﬁcantly greater (2–5 times) IFN (p=b0.0001 and p=0.0009,
respectively) following poly I:C stimulation compared to BVDV-
infected BT cells. Signiﬁcant differences in IFN activity were also
evident between AT and BT cells stimulated with poly I:C in lieu of
viral infection and later restimulated with additional poly I:C
(p=0.0019). AT cells stimulated with poly I:C, either once or twice,
synthesized signiﬁcantly greater (p=0.0020) IFN than unstimulated
AT cells, and nearly twice the IFN concentration synthesized by BT
cells stimulated once or twice with poly I:C. (Fig. 6).
BVDV RNA electroporation
To determine whether restricted viral replication in AT cells was
due to differences in the intracellular environment, BVDV RNA was
electroporated into AT and BT cells and assayed for levels of viral
replication by titrating viruses in cell culture. BVDV viral RNA
replicated in both AT and BT cells following electroporation (data
not shown). AT cells electroporated with BVDV NY-1 RNA had
signiﬁcantly less (p=0.0273) viral replication with an average titer of
2.18±0.259 TCID50, in comparison to BT cells which had an average
titer of 4.28±1.26 TCID50. AT and BT cells electroporated with BVDV
CO-06 RNA did not show any signiﬁcant difference (p=0.5093) in
viral replication, with a mean titer of 2.06±0.277 TCID50 in AT cells
and 2.74±0.652 TCID50 in BT cells.
Discussion
Results of the present study indicate that, compared to bovine
cells, alpaca cells have a limited permissiveness to BVDV infection.
Both alpaca and bovine origin noncytopathic BVDV isolates exhibited
reduced growth rates in alpaca cells when compared to bovine cells,
with up to 3–5 log TCID50 difference in infectivity at 72 hour post-
infection. This correlated with decreased intensity and frequency of
BVDV-speciﬁc antigen staining in alpaca cells compared to bovine
cells infected with the BVDV isolates. The lower viral titers and
diminished BVDV antigen staining in the alpaca cells compared to the
bovine cells suggests that alpaca cells are less permissive than BT cells
to BVDV infection. While the cells used in the present study had
different tissue origins, this did not inﬂuence the interpretation of
results since BVDV replicates efﬁciently in both testicular and
turbinate cells (Gil et al., 2006b; Topliff and Kelling, 1998).
Restricted replication of BVDV in AT cells corresponds to previous
results observed in camel ﬁbroblast cells in which BVDV and border
disease virus infected the camel cells but only to a limited extent
(Klopries et al., 1995). BVDV isolates, noncytopathic (ncp) Iowa and
cytopathic (cp) Ug59 did not replicate in camel ﬁbroblast cells,
although infection of different passage levels of camel ﬁbroblast cells
with different pestivirus isolates showed that some BVDV and border
disease virus isolates did replicate. Only a few camel ﬁbroblast cells
showed evidence of viral antigen deposition (Klopries et al., 1995),
which correlates with the diminished BVDV antigen staining of AT
cells compared to BT cells in the present study.
Restricted replication of pestiviruses in cells outside of the natural
host species as observed in the present study is consistent with
previous reports. Wieringa-Jelsma et al. (2006) showed that BVDV
was able to infect feeder pigs but transmission was limited, with only
one out of ten animals in contact with BVDV-inoculated pigs
becoming infected with BVDV based on isolation of virus from
leukocytes or presence of antibody. None of the infected animals
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The reduced permissiveness of alpaca cells to BVDV infection
reported in this study and the diminished clinical disease following
BVDV infection in alpacas is similar to the report that pigs are less
permissive to BVDV infection and did not exhibit clinical signs of
disease following infection with BVDV1 or BVDV2 (Walz et al., 1999).
BVDV1 was isolated from serum and tissue samples collected from
infected pigs; however, BVDV2 was isolated only from tissue samples
(Walz et al., 1999). The differences seen between BVDV1 and BVDV2
infections in pigs correlates with our observations in alpaca and
bovine cell culture. Alpaca cells were more permissive to BVDV1
infections with BVDV1 replicating to a signiﬁcantly (p=0.0238)
higher titer compared to BVDV2 in alpaca cells, with the BVDV1
alpaca isolate CO-06 having a signiﬁcantly greater titer than BVDV1
bovine isolate NY-1 (p=0.0307) and the BVDV2 isolates 890 and
7937 (p=0.0344). To date, BVDV isolates from alpacas have been
type 1b (Carman et al., 2005; Foster et al., 2007; Goyal et al., 2002;
Kim et al., 2009; Mattson et al., 2006; Topliff et al., 2009). This
suggests that alpaca cells are more permissive and better adapted for
infection with BVDV1 than BVDV2. The predominance of BVDV1b in
alpacas could also be a reﬂection of the regional predominance of
BVDV1b in nature.
It may be possible that increased interaction between New World
camelids and cattle has allowed for the expansion in host range of
BVDV. Other viruses such as inﬂuenza virus can mutate and infect a
wide range of hosts. Avian inﬂuenza viruses with mutations in the
hemagglutinin protein at a speciﬁc arginine residue (Arg 193) were
shown to have an increased afﬁnity for human cellular receptors
(Stevens et al., 2008). Infection of human epithelial cells with
infectious severe acute respiratory syndrome (SARS) coronavirus
clones carrying mutations found in the original zoonotic isolate
showed increased growth in the human epithelial cells in comparison
to cells from civets, the original host of the zoonotic strain (Sheahan
et al., 2008). In both the case of inﬂuenza virus and SARS virus,
differing species (human, avian, and civet) were living in close
proximity previous to the virus acquiring expanded host speciﬁcity.
The limited permissiveness of AT cells to BVDV infection may be a
result of the greater IFN expression in AT cells acting to inhibit BVDV
replication. In our study, ncp BVDV viruses were poor inducers of
type I IFN with no signiﬁcant difference in IFN induction between
alpaca and bovine cells following infection, which corresponds to
previous work (Gil et al., 2006a; Schweizer et al., 2006). However,
alpaca cells synthesized a signiﬁcantly greater level of IFN following
stimulation with poly I:C compared to bovine cells. Similarly, BVDV-
infected alpaca cells responded to poly I:C stimulation with
signiﬁcantly greater levels of IFN synthesis than bovine cells. IFN
responses are an essential component of the host innate immune
defense against viral infections. The more robust IFN response of
alpaca cells compared to bovine cells following poly I:C stimulation
alone and following infection with ncp BVDV may be the basis for
decreased permissiveness of AT cells compared to BT cells.
Replication of classical swine fever virus, a pestivirus, was inhibited
by recombinant type I IFN (Xia et al., 2005). Suppression of IFN
synthesis in BVDV-infected cells has been associated with BVDV
proteins Npro and Erns. Lymphoid cells have been recovered from
cattle that are able to produce IFN after infection with ncp BVDV.
These bovine lymphoid cells synthesize type I IFN without expres-
sing NS3 antigens (Brackenbury et al., 2005). Similarly, the elevated
IFN response in alpaca cells when stimulated with dsRNA, in addition
to the reduced inhibition of IFN synthesis following post-infection
stimulation with dsRNA in cell culture, suggests that alpaca cells may
be able to produce IFN effectively following infection in the host. The
reduced or lack of antigen expression in IFN producing bovine
lymphoid cells closely parallels the reduced antigen expression seen
in our study with alpaca cells.To characterize post-entry intracellular resistance to viral replica-
tion, AT and BT cells were transfected with RNA from BVDV NY-1 or
BVDV CO-06 and progeny virus titered to determine levels of
replication. NY-1 BVDV replicated to signiﬁcantly higher levels in BT
cells than in AT cells, while BVDV CO-06 replicated to comparable
levels in both cell types. These results correlate with results of the IFN
inhibition assay. Both alpaca and bovine cells infected with BVDV CO-
06, followed by stimulationwith poly I:C, were able to synthesize high
levels of IFN, which could interfere with the replication of the virus
following both infection and electroporation of BVDV RNA. BVDV NY-
1 signiﬁcantly inhibited IFN synthesis in bovine cells, but not in alpaca
cells, also correlating with the increased replication seen in bovine but
not alpaca cells following transfection. The Erns protein of BVDV has
been shown to inhibit activation of IFN synthesis by extracellular
dsRNA but not intracellular RNA, which may also explain the reduced
replication of BVDV CO-06 following transfection (Magkouras et al.,
2008). Additional genomic studies directed toward deﬁning genomic
differences between CO-06 and NY-1 may help to elucidate this
phenomenon.
Results of the present study indicate limited permissiveness of
alpaca cells to BVDV infection. Previously, alpacas and other New
World camelids had been shown to be resistant to a number of viral
diseases, including foot and mouth disease (Wemery and Kaaden,
2004) and acute BVDV infection (Wentz et al., 2003). Acute BVDV-
infected alpacas exhibit diminished clinical parameters of disease,
such as antigen deposition in lymphoid tissues, when compared to
clinical signs in acute BVDV-infected calves (Kelling et al., 1990, 2002;
Wentz et al., 2003). The reduced replication of BVDV in alpaca cell
culture compared to bovine cell culture and the increased IFN
response following poly I:C stimulation suggests that reduced clinical
expression of BVDV infection in alpacas may be due to limited
permissiveness of alpaca cells to BVDV infection compared to bovine
cells.
Materials and methods
Cells and viruses
Bovine turbinate (BT, National Veterinary Services Laboratory,
USDA, Ames, IA) and Madin–Darby bovine kidney (MDBK, CCL-22,
American Type Culture Collection, Manassas, VA) cells were grown in
Dulbecco's Modiﬁed Eagle Medium (DMEM) (Invitrogen, Carlsbad,
CA) supplemented with 10% equine serum (Hyclone, Logan, UT).
Primary alpaca testicular (AT) cells were harvested from testicular
tissue of healthy adult alpacas collected at the time of castration and
were grown in DMEM supplemented with 10% fetal bovine serum
(FBS) (Hyclone), 0.5 μg/ml fungizone (Invitrogen) and 100 μg/ml
gentamycin (Sigma-Aldrich, St. Louis, MO). NCL1-ISRE-Luc-Hygro
cells, a modiﬁed bovine uterine cell line constitutively expressing an
IFN response element gene coupled with ﬁreﬂy luciferase, were
maintained in DMEM supplemented with 10% equine serum and
300 μg/ml hygromycin (Cellgro, Manassas, VA). Bovine cell lines were
free of adventitious BVDV and fetal bovine serum free of BVDV
antibodies. BVDV 890 (Animal, Plant, and Health Inspection Service,
Center for Veterinary Biologics, Ames, IA) and BVDV 7937 (Kelling
et al., 1990) were originally isolated from acute BVDV-infected and PI
calves, respectively, and were determined to be BVDV2 ncp isolates.
BVDV NY-1 (National Veterinary Sciences Laboratory), a prototypical
BVDV1 ncp virus, was isolated from an acute BVDV-infected calf.
BVDV CO-06 is an alpaca origin BVDV1 isolate recovered from a PI
alpaca at the University of Nebraska. BT cell monolayers at 90%
conﬂuency were individually infected with each BVDV isolate at a
multiplicity of infection (m.o.i.) of 1 in 75 cm2 tissue culture ﬂasks and
incubated at 37 °C in a humidiﬁed incubator with 5% CO2 for 4 days.
Following a single freeze–thaw cycle, 1 ml aliquots of mock- and viral-
infected BT cell lysates were stored at −80 º C.
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Polyriboinosinic polyribocytidylic acid (poly I:C) (Amersham
Biosciences, Piscataway, NJ) was reconstituted in phosphate buffered
saline (PBS) to a stock concentration of 2 mg/ml, passed through a 21
gauge needle to shear the RNA, and stored in aliquots at −80 °C.
BVDV replication
BT or AT cells were seeded at a density of 1×105 cells/well into 6
well culture plates and incubated at 37 °C in a humidiﬁed incubator
with 5% CO2 until 90% conﬂuent. Cells were then infected with virus at
an m.o.i. of 0.3 and incubated at 37 °C for 1.5 hours with rocking.
Following adsorption, cells were washed with DMEM and incubated
in fresh media supplemented with 5% equine serum for BT cells or 5%
FBS for AT cells. Cells were monitored by microscopic examination
and frozen at −80 °C 0, 1.5, 3, 6, 9, 12, 24, 48, or 72 hour post-
infection. Cell lysates were thawed on ice and virus titers determined
at each time point (Brodersen and Kelling, 1999).
Virus preparation for IFN assay
Virus preparation for the IFN assay as been previously described
(Gil et al., 2006a). Brieﬂy, BT or MDBK cells were inoculated with
BVDV NY-1 or CO-06 virus stock at an m.o.i. of 1 and incubated at
37 °C for 4 days, then frozen at −80 °C. Flasks were thawed; cell
lysates harvested and centrifuged at 2000g for 30 minutes at 4 °C to
clarify the supernatant. The supernatant was then transferred to
ultracentrifuge tubes and centrifuged at 100,000g for 2 hours at 4 °C.
The resulting viral pellet was resuspended in 500 μl DMEM and stored
in aliquots at −80 °C.
IFN reporter gene assay
BT or AT cells were seeded onto 6 well plates at a cell density of
1×105 and grown to 90% conﬂuency. Cells were then infected with
pelleted virus isolates at an m.o.i. of 10 and incubated at 37 °C for
24 hours, then frozen at−80 °C. The plates were thawed and the cell
lysate supernatant clariﬁed by centrifugation at 2000g for 30 minutes
at 4 °C. The pH of the clariﬁed supernatant was adjusted to pH 2 with
2 M HCl. After incubation at 4 °C for 24 hours, the pH of the
supernatant was adjusted to pH 7 using 2 M NaOH. Test samples
(500 μl) were added to 12 well plates of NCL1-ISRE-Luc-Hygro cells
(Gil et al., 2006a) prepared 12 hours earlier by adding 1.5×105 cells/
well and incubating at 37 °C. After addition of the test sample, the
NCL1-ISRE-Luc-Hygro cells were incubated for 8 hours, followed by
cell lysis in 100 μl of passive lysis buffer (Promega, Madison, WI) (Gil
et al., 2006a). The luciferase assay was performed using the ﬁreﬂy
luciferase assay system (Promega) according to the manufacturer's
instructions, with sample luminescence measured by a FLUOStar
luminometer (BMG Labtech, Offenburg, Germany).
IFN inhibition assay
BT or AT cells were seeded onto 6 well plates at a cell density of
1×105 and grown to 90% conﬂuency. Cells were then infected with
BVDV1 NY-1 or CO-06 at an m.o.i. of 1 and incubated for 48 hours at
37 °C, at which time poly I:C was added to the cells at a concentration
of 50 μg/ml (Baigent et al., 2002; Gil et al., 2006a). Following
incubation for 20 hours at 37 °C, cells were harvested by a freeze–
thaw cycle at−80 °C and pH adjusted to pH 2 for 24 hours at 4 °C to
inactivate virus. The pH of the cell lysates was then adjusted to pH 7
and added to reporter cell plates containing NCL1-ISRE-Luc-Hygro
cells and assayed as described previously (Gil et al., 2006a).RNA electroporation
Puriﬁed viral RNA was extracted from pelleted virus stocks using
TriZol LS (Invitrogen) according to the manufacturer's instructions.
The concentration and purity of the RNA was determined by
measuring the UV absorbance at 260 and 280 nm (Model DU-64,
Beckman Coulter, Fullerton, CA). Conﬂuentmonolayer ﬂasks of AT and
BT cells were washed with 10 ml CMF-PBS, trypsinized with 5 ml
0.05% trypsin-EDTA, resuspended in 5 ml DMEM, and centrifuged at
1000 rpm at 4 °C for 10 minutes. The resulting cell pellet was
resuspended in 5 ml “E” buffer (DMEMwith 1.25% dimethysulfoxide).
Cells (1×105) were resuspended in 400 μl of “E” buffer and placed
into a 0.4 cm gap electroporation cuvette, then electroporated with
2 μg of the puriﬁed viral RNA using a Bio-Rad GenePulser electro-
porator with an exponential curve pulse at 250 V, 950 μF, ∞
capacitance. After electroporation, cells were recovered in 2 ml of
recovery medium (“E” buffer with 5% serum) and placed into a 6 well
plate. After ensuring even cell distribution in the well, an aliquot of
cell suspension was removed and placed into wells of a 12 well plate
with 1 ml of recovery buffer. Cell plates were incubated for 4 days at
37 °C in a humidiﬁed incubator with 5% CO2. The 12 well plates were
ﬁxed and viral antigen detected using an enzyme-linked immunoas-
say as previously described (Brodersen and Kelling, 1999) using mAb
348 (VMRD, Pullman,WA), speciﬁc for BVDV E2 protein, while cells in
the 6 well plates were frozen at −80 °C and cell lysates assayed for
viral titers (Gil et al., 2006a).
Statistical analyses
Statistical analyses were carried out with the SAS statistical
software program (Cary, NC) using the Student t test and least square
means test. The level of signiﬁcance was set at 0.05.
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